These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10969041)

  • 21. Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study.
    Kawut SM; Barr RG; Johnson WC; Chahal H; Tandri H; Jain A; Bristow MR; Kizer JR; Bagiella E; Lima JA; Bluemke DA
    Biomarkers; 2010 Dec; 15(8):731-8. PubMed ID: 20923324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice.
    Frutkin AD; Otsuka G; Stempien-Otero A; Sesti C; Du L; Jaffe M; Dichek HL; Pennington CJ; Edwards DR; Nieves-Cintrón M; Minter D; Preusch M; Hu JH; Marie JC; Dichek DA
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1251-7. PubMed ID: 19325140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tissue inhibitor of matrix metalloproteinase-4 (TIMP-4) in systemic sclerosis patients with elevated pulmonary arterial pressure.
    Elias GJ; Ioannis M; Theodora P; Dimitrios PP; Despoina P; Kostantinos V; Charalampos K; Vassilios V; Petros SP
    Mediators Inflamm; 2008; 2008():164134. PubMed ID: 19190762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions.
    West J; Harral J; Lane K; Deng Y; Ickes B; Crona D; Albu S; Stewart D; Fagan K
    Am J Physiol Lung Cell Mol Physiol; 2008 Nov; 295(5):L744-55. PubMed ID: 18723761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells.
    Bull TM; Meadows CA; Coldren CD; Moore M; Sotto-Santiago SM; Nana-Sinkam SP; Campbell TB; Geraci MW
    Am J Respir Cell Mol Biol; 2008 Dec; 39(6):706-16. PubMed ID: 18587055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CPU86017 and its isomers improve hypoxic pulmonary hypertension by attenuating increased ETA receptor expression and extracellular matrix accumulation.
    Li N; Dai DZ; Dai Y
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):541-52. PubMed ID: 18548232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathology of pulmonary hypertension.
    Tuder RM; Marecki JC; Richter A; Fijalkowska I; Flores S
    Clin Chest Med; 2007 Mar; 28(1):23-42, vii. PubMed ID: 17338926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphometric analysis of the lung vasculature after extracorporeal membrane oxygenation treatment for pulmonary hypertension in newborns.
    van Heijst A; Haasdijk R; Groenman F; van der Staak F; Hulsbergen-van de Kaa C; de Krijger R; Tibboel D
    Virchows Arch; 2004 Jul; 445(1):36-44. PubMed ID: 15175881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.
    Lalu MM; Gao CQ; Schulz R
    Mol Cell Biochem; 2003 Sep; 251(1-2):61-6. PubMed ID: 14575305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice.
    Camp TM; Tyagi SC; Senior RM; Hayden MR; Tyagi SC
    Diabetologia; 2003 Oct; 46(10):1438-45. PubMed ID: 12928773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.
    Li YY; Feldman AM
    Drugs; 2001; 61(9):1239-52. PubMed ID: 11511020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice.
    Pascaud MA; Griscelli F; Raoul W; Marcos E; Opolon P; Raffestin B; Perricaudet M; Adnot S; Eddahibi S
    Am J Respir Cell Mol Biol; 2003 Oct; 29(4):449-57. PubMed ID: 12714372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases and their inhibitors in pulmonary hypertension.
    Chelladurai P; Seeger W; Pullamsetti SS
    Eur Respir J; 2012 Sep; 40(3):766-82. PubMed ID: 22523364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats.
    Vieillard-Baron A; Frisdal E; Eddahibi S; Deprez I; Baker AH; Newby AC; Berger P; Levame M; Raffestin B; Adnot S; d'Ortho MP
    Circ Res; 2000 Sep; 87(5):418-25. PubMed ID: 10969041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer limits monocrotaline-induced pulmonary vascular remodeling in rats.
    Vieillard-Baron A; Frisdal E; Raffestin B; Baker AH; Eddahibi S; Adnot S; D'Ortho MP
    Hum Gene Ther; 2003 Jun; 14(9):861-9. PubMed ID: 12828857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats.
    Partovian C; Adnot S; Raffestin B; Louzier V; Levame M; Mavier IM; Lemarchand P; Eddahibi S
    Am J Respir Cell Mol Biol; 2000 Dec; 23(6):762-71. PubMed ID: 11104729
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.